Resona Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.5M Sell
371,945
-43,650
-11% -$3.9M 0.18% 98
2026
Q1
$29.7M Buy
415,595
+6,396
+2% +$493K 0.15% 125
2025
Q4
$32.5M Sell
409,199
-17,191
-4% -$1.36M 0.16% 120
2025
Q3
$32.2M Sell
426,390
-35,532
-8% -$2.44M 0.15% 126
2025
Q2
$31.8M Buy
461,922
+5,714
+1% +$375K 0.16% 132
2025
Q1
$30.9M Buy
456,208
+28,387
+7% +$1.7M 0.18% 120
2024
Q4
$19.2M Sell
427,821
-13,197
-3% -$740K 0.11% 165
2024
Q3
$27.7M Sell
441,018
-13,188
-3% -$769K 0.16% 124
2024
Q2
$26.8M Sell
454,206
-7,368
-2% -$461K 0.16% 125
2024
Q1
$36.8M Buy
+461,574
New +$35.3M 0.22% 95

Other funds holding CVS

Resona Asset Management's CVS Position: Q2 2026 in Review

Resona Asset Management reduced its CVS Health (CVS) stake by 11% in Q2 2026, selling an estimated $3.9M and leaving 371,945 shares worth $38.5M. The position accounts for 0.18% of the portfolio, ranked #98.

Resona Asset Management first reported a position in CVS in Q1 2024 and has held it in 10 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Resona Asset Management held 371,945 shares of CVS Health worth $38.5M as of Q2 2026.
  • Resona Asset Management sold 43,650 CVS Health shares in Q2 2026, an estimated $3.9M.
  • CVS Health made up 0.18% of Resona Asset Management's portfolio in Q2 2026, its #98 holding.
  • Resona Asset Management first reported a position in CVS Health in Q1 2024 and has held it in 10 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.